These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease. Luketic VA, Sanyal AJ. Gastroenterologist; 1994 Mar; 2(1):74-9. PubMed ID: 8055235 [Abstract] [Full Text] [Related]
3. Treatment of chronic active hepatitis and primary biliary cirrhosis with ursodeoxycholic acid. Güldütuna S, Leuschner U, Imhof M, Zimmer G. Z Gastroenterol; 1992 Mar; 30 Suppl 1():49-54. PubMed ID: 1449017 [Abstract] [Full Text] [Related]
4. New therapeutical indications of ursodeoxycholic acid. Copaci I, Micu L, Iliescu L, Voiculescu M. Rom J Gastroenterol; 2005 Sep; 14(3):259-66. PubMed ID: 16200237 [Abstract] [Full Text] [Related]
5. Therapy with ursodeoxycholic acid in cholestatic liver disease. Van de Meeberg PC, van Erpecum KJ, van Berge-Henegouwen GP. Scand J Gastroenterol Suppl; 1993 Sep; 200():15-20. PubMed ID: 8016564 [Abstract] [Full Text] [Related]
6. [Treatment of cholestatic liver diseases with ursodeoxycholic acid]. Boberg KM, Schrumpf E. Tidsskr Nor Laegeforen; 1997 Sep 30; 117(23):3370-3. PubMed ID: 9411890 [Abstract] [Full Text] [Related]
10. [Treatment of cholestatic liver diseases; the role of ursodeoxycholic acid]. Stiehl A. Z Gastroenterol; 1992 Oct 30; 30(10):743-7. PubMed ID: 1441678 [Abstract] [Full Text] [Related]
12. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection? Hay JE. Liver Transpl Surg; 1998 Sep 30; 4(5 Suppl 1):S9-17. PubMed ID: 9742489 [Abstract] [Full Text] [Related]
13. [Treatment of cholestatic liver diseases]. Gatzen M, Pausch J. Med Klin (Munich); 2002 Mar 15; 97(3):152-9. PubMed ID: 11957790 [Abstract] [Full Text] [Related]